Answers are grounded in this paper and cite their sources.
Protease inhibitors remain an important component of cART despite their adverse effects on bone. A better understanding of factors that drive HIV/cART-induced bone loss is needed to stem the rising rate of fracture in the HIV-infected population.
No takes yet. Share an insight, caveat, or question.
Moran et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: